金达莱：拟向济慈医疗增资2.8亿元取得其34%股权

Core Viewpoint - The company is optimistic about the development prospects of stem cell technology and plans to optimize its industrial structure to seek new opportunities for growth and enhance its risk resistance [1] Group 1: Investment and Strategic Moves - The company intends to invest 280 million yuan in Yunnan Jici Medical Technology Co., Ltd. to acquire a 34% stake [1]